See more : Aethlon Medical, Inc. (AEMD) Income Statement Analysis – Financial Results
Complete financial analysis of Quoin Pharmaceuticals, Ltd. (QNRX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Quoin Pharmaceuticals, Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Goodwill E-Health Info Co., Ltd. (688246.SS) Income Statement Analysis – Financial Results
- Kerry Group plc (KRYAY) Income Statement Analysis – Financial Results
- Ramkrishna Forgings Limited (RKFORGE.BO) Income Statement Analysis – Financial Results
- Steer Technologies Inc. (STEEF) Income Statement Analysis – Financial Results
- Shinozakiya, Inc. (2926.T) Income Statement Analysis – Financial Results
Quoin Pharmaceuticals, Ltd. (QNRX)
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -280.00K | 0.00 | -280.00K | 0.00 |
| Cost of Revenue | 103.44K | 103.64K | 104.12K | 104.77K | 227.06K | 125.72K | 104.22K | 89.13K | 18.27K |
| Gross Profit | -103.44K | -103.64K | -104.12K | -104.77K | -227.06K | -405.72K | -104.22K | -369.13K | -18.27K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 144.90% | 0.00% | 131.83% | 0.00% |
| Research & Development | 3.31M | 2.67M | 1.56M | 244.16K | 45.65K | 8.26M | 5.89M | 8.26M | 1.52M |
| General & Administrative | 6.07M | 6.58M | 4.50M | 1.43M | 1.51M | 7.97M | 4.20M | 7.97M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.07M | 6.58M | 4.50M | 1.43M | 1.51M | 7.97M | 4.20M | 7.97M | 1.06M |
| Other Expenses | 0.00 | 417.31K | -14.03M | -378.33K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 9.38M | 9.26M | 6.06M | 1.67M | 1.56M | 16.22M | 10.10M | 16.22M | 2.58M |
| Cost & Expenses | 9.38M | 9.26M | 6.06M | 1.67M | 1.56M | 16.22M | 10.10M | 16.22M | 2.60M |
| Interest Income | 692.82K | 95.75K | 1.37K | 47.02 | 0.00 | 0.00 | 0.00 | 0.00 | 1.03K |
| Interest Expense | 0.00 | 714.08K | 1.09M | 47.02K | 412.29K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 103.44K | 103.64K | 104.12K | 104.77K | 227.06K | 125.72K | 104.22K | 89.13K | 18.27K |
| EBITDA | -9.27M | -8.74M | -21.37M | -2.01M | -1.54M | -5.47M | -7.80M | -3.91M | -2.60M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -5,470.36% | 0.00% | -5,470.36% | 0.00% |
| Operating Income | -9.38M | -8.85M | -20.37M | -2.05M | -1.56M | 15.32M | 10.17M | 15.32M | -2.60M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -5,470.36% | 0.00% | -5,470.36% | 0.00% |
| Total Other Income/Expenses | 714.32K | -123.79K | -1.09M | -425.35K | 0.00 | 2.54M | -1.06M | 237.07K | -19.30K |
| Income Before Tax | -8.66M | -9.38M | -21.46M | -2.10M | -1.56M | 15.32M | 10.17M | 15.32M | -2.62M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -5,470.36% | 0.00% | -5,470.36% | 0.00% |
| Income Tax Expense | 22.38K | -104.04K | -12.94M | -331.31K | 1.55M | -161.14K | -1.17M | 147.94K | -1.00 |
| Net Income | -8.69M | -9.28M | -8.52M | -1.76M | -1.56M | 15.32M | 10.17M | 15.32M | -2.62M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -5,470.36% | 0.00% | -5,470.36% | 0.00% |
| EPS | -9.64 | -22.97 | -322.49 | -88.10 | -440.29 | 7.10K | 5.45K | 10.08K | -2.11K |
| EPS Diluted | -9.64 | -22.97 | -322.49 | -88.10 | -440.29 | 7.10K | 5.45K | 10.08K | -2.11K |
| Weighted Avg Shares Out | 900.92K | 403.88K | 26.42K | 20.02K | 3.54K | 2.16K | 1.87K | 1.52K | 1.24K |
| Weighted Avg Shares Out (Dil) | 901.10K | 403.88K | 26.42K | 20.02K | 3.54K | 2.16K | 1.87K | 1.52K | 1.24K |
4 Penny Stocks Making A Comeback In September, Time To Buy?
Penny stocks making a comeback to watch this week. The post 4 Penny Stocks Making A Comeback In September, Time To Buy?
Quoin Pharmaceuticals, Ltd. (QNRX) CEO Michael Myers on Q2 2022 Results - Earnings Call Transcript
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX ) Q2 2022 Earnings Conference Call August 18, 2022 8:30 AM ET Company Participants Gordon Dunn - Chief Financial Officer Michael Myers - Chief Executive Officer Denise Carter - Chief Operating Officer and Director Conference Call...
Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18th
ASHBURN, Va., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that its second quarter 2022 financial results will be...
Why Is Quoin Pharmaceuticals (QNRX) Stock Up 93% Today?
QNRX stock is nearly doubling after the company sought permission to cancel an announcement of share sales. The post Why Is Quoin Pharmaceuticals (QNRX) Stock Up 93% Today?
Best Penny Stocks To Buy Right Now? 4 To Watch Under $1
Penny stocks under $1 to watch. The post Best Penny Stocks To Buy Right Now?
Penny Stocks To Buy Now? 4 To Watch With Big News
Penny stocks to watch The post Penny Stocks To Buy Now? 4 To Watch With Big News appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Quoin Pharmaceuticals Stock Is Trading Higher
Quoin Pharmaceuticals (NASDAQ: QNRX) shares are trading higher Monday after the company announced it received U.S. Food and Drug Administration clearance to initiate clinical testing for its Investigational New Drug application for QRX003. QRX003 is Quoin's investigational product for.
Best Reddit Penny Stocks To Buy Now? 5 Trending Stocks To Watch Today
What are the best penny stocks to buy today? The post Best Reddit Penny Stocks To Buy Now?
Best Penny Stocks to Buy as 2021 Ends? 3 to Watch Right Now
Making a penny stocks watchlist today? Check these three out The post Best Penny Stocks to Buy as 2021 Ends?
Source: https://incomestatements.info
Category: Stock Reports